Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I [PDF]
A 43-year-old woman with genetically confirmed glycogen storage disease type Ib was suspected to have left breast cancer. Fluorodeoxyglucose-positron emission tomography showed high fluorodeoxyglucose accumulation in the whole liver as well as left ...
Takeshi Sato, MD +6 more
doaj +2 more sources
Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies [PDF]
Glycogen storage disease type I (GSDI) is an inherited metabolic disorder characterized by a deficiency of enzymes or proteins involved in glycogenolysis and gluconeogenesis, resulting in excessive intracellular glycogen accumulation.
Jiamin Zhong +10 more
doaj +2 more sources
Impact of glycogen storage disease type I on adult daily life: a survey [PDF]
Background Glycogen storage disease type I (GSD I) is a rare autosomal recessive disorder of carbohydate metabolism characterized by recurrent hypoglycaemia and hepatomegaly. Management of GSD I is demanding and comprises a diet with defined carbohydrate
Sven F. Garbade +6 more
doaj +2 more sources
Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients [PDF]
Patients and Methods: A retrospective chart review of 32 GSD- I patients, followed at the American University of Beirut Medical Center, between 2007 and 2018 was conducted. Diagnosis was confirmed by enzymatic and/or genetic studies.
Bilal Aoun +5 more
doaj +2 more sources
Von Gierke Disease (Glycogen Storage Disease Type I) and Life-Threatening Abdominal Aortic Aneurysm: A Case Report of an Extremely Rare Condition [PDF]
Von Gierke disease, also known as glycogen storage disease type I, co-existent with an abdominal aortic aneurysm (AAA), is an extremely rare combination of diseases that requires challenging therapeutic measures.
Apostolos G. Pitoulias +5 more
doaj +2 more sources
Liver transplantation in glycogen storage disease type I. [PDF]
Glycogen storage disease type I (GSDI), an inborn error of carbohydrate metabolism, is caused by defects in the glucose-6-transporter/glucose-6-phosphatase complex, which is essential in glucose homeostasis. Two types exist, GSDIa and GSDIb, each caused by different defects in the complex.
Boers SJ, Visser G, Smit PG, Fuchs SA.
europepmc +5 more sources
Growth impairment in glycogen storage disease type I versus types III/VI/IX: a cross-sectional study [PDF]
Background Growth retardation is common in glycogen storage disease (GSD), though the relative contributions of hormonal and metabolic factors remain unclear.
Xiaohui Wu, Yueyu Sun, Min Yang
doaj +2 more sources
LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE [PDF]
Abstract A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.
Shunzaburo Iwatsuki +2 more
exaly +3 more sources
Glycogen storage disease type I: clinical and laboratory profile
OBJECTIVES: To characterize the clinical, laboratory, and anthropometric profile of a sample of Brazilian patients with glycogen storage disease type I managed at an outpatient referral clinic for inborn errors of metabolism.
Berenice L. Santos +7 more
doaj +8 more sources
Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement [PDF]
Background Glycogen storage disease type I (GSDI) is an inborn error of carbohydrate metabolism caused by mutations of either the G6PC gene (GSDIa) or the SLC37A4 gene (GSDIb).
Alessandro Rossi +9 more
doaj +2 more sources

